ID: ALA4520122

Max Phase: Preclinical

Molecular Formula: C48H58O16

Molecular Weight: 890.98

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1c(C)c(OC(=O)c2c(C)c(C)c(OC[C@H](O)[C@@H](O)COc3c(C)c(C)c(C(=O)Oc4c(C)c(C)c(C(=O)O)c(OC)c4C)c(OC)c3C)c(C)c2OC)c(C)c(C)c1C(=O)O

Standard InChI:  InChI=1S/C48H58O16/c1-19-25(7)39(29(11)41(57-13)33(19)45(51)52)63-47(55)35-21(3)23(5)37(27(9)43(35)59-15)61-17-31(49)32(50)18-62-38-24(6)22(4)36(44(60-16)28(38)10)48(56)64-40-26(8)20(2)34(46(53)54)42(58-14)30(40)12/h31-32,49-50H,17-18H2,1-16H3,(H,51,52)(H,53,54)/t31-,32-/m0/s1

Standard InChI Key:  IVRBPHXRZGLNDL-ACHIHNKUSA-N

Associated Targets(Human)

Proteasome assembly chaperone 3 51 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PAC1-PAC2 complex 49 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 890.98Molecular Weight (Monoisotopic): 890.3725AlogP: 7.44#Rotatable Bonds: 17
Polar Surface Area: 223.04Molecular Species: ACIDHBA: 14HBD: 4
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 4#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.48CX Basic pKa: CX LogP: 10.37CX LogD: 3.83
Aromatic Rings: 4Heavy Atoms: 64QED Weighted: 0.06Np Likeness Score: 0.33

References

1. Ohsawa K, Yoshida M, Izumikawa M, Takagi M, Shin-Ya K, Goshima N, Hirokawa T, Natsume T, Doi T..  (2018)  Synthesis and biological evaluation of thielocin B1 analogues as protein-protein interaction inhibitors of PAC3 homodimer.,  26  (23-24): [PMID:30455074] [10.1016/j.bmc.2018.11.001]

Source